Plain-English translation of NCT07321886 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a medication called , which is given as a weekly injection under the skin, to see if it can help adults with obesity or overweight lose weight. The trial will compare four different doses of the medication against a placebo (a dummy injection with no active medicine) to find out which dose works best and is safest.
Current options for weight loss are limited, and many people struggle to lose weight through diet and exercise alone. This medication is being studied to offer a new treatment option for people who are overweight or have obesity but do not have type 2 diabetes.
You likely qualify if…
You likely don't qualify if…
You will receive either the new medication or a placebo as a weekly injection for about 75 weeks (about 18 months). You'll visit the study clinic regularly so the doctors can check how you're doing and monitor your weight and health. If you have prediabetes, you may be invited to continue in an additional 2-year phase to see how the medication affects your blood sugar over a longer time.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States